图维生物医药科技（苏州）有限公司致力于RNA合成的研究和开发，近日，我们公司在RNA合成领域取得了令人瞩目的突破，成功合成了长度达到300nt的RNA分子。这一进展不仅彰显了我们在技术上的领先地位，更为生物医药研究和应用带来了新的可能性。

Recently, David Liu's team has made another breakthrough in gene editing technology. The new system, eePASSIGE, can insert exogenous fragments up to 10kb in length, with an integration efficiency 16 times higher than previous systems.

近日，我公司苏州图维生物在RNA的合成中又一次取得了进步，依托我们的技术平台nMECA，我们已成功实现了200nt RNA的酶促合成。

In the realm of genome editing, precision is paramount. Scientists strive to achieve pinpoint accuracy when manipulating genetic material, whether for basic research or therapeutic applications. One of the key tools enabling this precision is the single-guide RNA (sgRNA). In this blog post, we'll explore various strategies for designing sgRNAs to facilitate precise genome editing.

CRISPR-Cas9 technology has revolutionized the field of genome editing, offering unprecedented precision and efficiency in targeted genetic modifications. One of the critical components of CRISPR-mediated genome editing is the delivery of single guide RNA (sgRNA) to the target cells. Optimizing sgRNA delivery methods is crucial for maximizing the efficiency and specificity of CRISPR editing. In this blog post, we will explore various strategies for enhancing sgRNA delivery, thereby improving CRISPR efficiency.